#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=Poultry production forms an integral part of the economy with many socio-economic and cultural values attached to the birds in most developing countries including Uganda .
2-1	16-23	Poultry	animal|abstract[3]	new|new[3]	coref|coref	3-10|3-9[12_3]
2-2	24-34	production	abstract[3]	new[3]	_	_
2-3	35-40	forms	_	_	_	_
2-4	41-43	an	_	_	_	_
2-5	44-52	integral	_	_	_	_
2-6	53-57	part	_	_	_	_
2-7	58-60	of	_	_	_	_
2-8	61-64	the	abstract[4]	new[4]	_	_
2-9	65-72	economy	abstract[4]	new[4]	_	_
2-10	73-77	with	_	_	_	_
2-11	78-82	many	abstract[5]	new[5]	_	_
2-12	83-97	socio-economic	abstract[5]	new[5]	_	_
2-13	98-101	and	abstract[5]	new[5]	_	_
2-14	102-110	cultural	abstract[5]	new[5]	_	_
2-15	111-117	values	abstract[5]	new[5]	_	_
2-16	118-126	attached	abstract[5]	new[5]	_	_
2-17	127-129	to	abstract[5]	new[5]	_	_
2-18	130-133	the	abstract[5]|animal[6]	new[5]|new[6]	coref	5-30[0_6]
2-19	134-139	birds	abstract[5]|animal[6]	new[5]|new[6]	_	_
2-20	140-142	in	abstract[5]	new[5]	_	_
2-21	143-147	most	abstract[5]|place[7]	new[5]|new[7]	_	_
2-22	148-158	developing	abstract[5]|place[7]	new[5]|new[7]	_	_
2-23	159-168	countries	abstract[5]|place[7]	new[5]|new[7]	_	_
2-24	169-178	including	abstract[5]|place[7]	new[5]|new[7]	_	_
2-25	179-185	Uganda	abstract[5]|place[7]|place	new[5]|new[7]|new	coref	32-51
2-26	186-187	.	_	_	_	_

#Text=However , one of the major challenges to improved poultry production is the prevalence of poultry diseases that threaten the intensification of production .
3-1	188-195	However	_	_	_	_
3-2	196-197	,	_	_	_	_
3-3	198-201	one	abstract[9]	new[9]	coref	3-13[13_9]
3-4	202-204	of	abstract[9]	new[9]	_	_
3-5	205-208	the	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-6	209-214	major	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-7	215-225	challenges	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-8	226-228	to	abstract[9]|abstract[10]	new[9]|new[10]	_	_
3-9	229-237	improved	abstract[9]|abstract[10]|abstract[12]	new[9]|new[10]|giv[12]	coref	3-23[0_12]
3-10	238-245	poultry	abstract[9]|abstract[10]|animal|abstract[12]	new[9]|new[10]|giv|giv[12]	coref	3-16
3-11	246-256	production	abstract[9]|abstract[10]|abstract[12]	new[9]|new[10]|giv[12]	_	_
3-12	257-259	is	_	_	_	_
3-13	260-263	the	abstract[13]	giv[13]	_	_
3-14	264-274	prevalence	abstract[13]	giv[13]	_	_
3-15	275-277	of	abstract[13]	giv[13]	_	_
3-16	278-285	poultry	abstract[13]|animal|abstract[15]	giv[13]|giv|new[15]	coref|coref	4-4[18_15]|10-9[64_0]
3-17	286-294	diseases	abstract[13]|abstract[15]	giv[13]|new[15]	_	_
3-18	295-299	that	abstract[13]|abstract[15]	giv[13]|new[15]	_	_
3-19	300-308	threaten	abstract[13]|abstract[15]	giv[13]|new[15]	_	_
3-20	309-312	the	abstract[13]|abstract[15]|abstract[16]	giv[13]|new[15]|new[16]	_	_
3-21	313-328	intensification	abstract[13]|abstract[15]|abstract[16]	giv[13]|new[15]|new[16]	_	_
3-22	329-331	of	abstract[13]|abstract[15]|abstract[16]	giv[13]|new[15]|new[16]	_	_
3-23	332-342	production	abstract[13]|abstract[15]|abstract[16]|abstract	giv[13]|new[15]|new[16]|giv	coref	7-9[39_0]
3-24	343-344	.	_	_	_	_

#Text=Among these are gastrointestinal parasitic diseases notably , coccidiosis .
4-1	345-350	Among	_	_	_	_
4-2	351-356	these	_	_	_	_
4-3	357-360	are	_	_	_	_
4-4	361-377	gastrointestinal	abstract[18]	giv[18]	_	_
4-5	378-387	parasitic	abstract[18]	giv[18]	_	_
4-6	388-396	diseases	abstract[18]	giv[18]	_	_
4-7	397-404	notably	abstract[18]	giv[18]	_	_
4-8	405-406	,	_	_	_	_
4-9	407-418	coccidiosis	_	_	_	_
4-10	419-420	.	_	_	_	_

#Text=Coccidiosis is a disease caused by parasites of the genus Eimeria and phylum Apicomplexa with a complex life cycle , affecting mainly the intestinal tract of many species of birds .
5-1	421-432	Coccidiosis	abstract	new	coref	5-3[20_0]
5-2	433-435	is	_	_	_	_
5-3	436-437	a	abstract[20]	giv[20]	ana	6-1[0_20]
5-4	438-445	disease	abstract[20]	giv[20]	_	_
5-5	446-452	caused	abstract[20]	giv[20]	_	_
5-6	453-455	by	abstract[20]	giv[20]	_	_
5-7	456-465	parasites	abstract[20]|animal[21]	giv[20]|new[21]	_	_
5-8	466-468	of	abstract[20]|animal[21]	giv[20]|new[21]	_	_
5-9	469-472	the	abstract[20]|animal[21]|abstract[23]	giv[20]|new[21]|new[23]	coref	8-3[49_23]
5-10	473-478	genus	abstract[20]|animal[21]|animal|abstract[23]	giv[20]|new[21]|new|new[23]	_	_
5-11	479-486	Eimeria	abstract[20]|animal[21]|abstract[23]	giv[20]|new[21]|new[23]	_	_
5-12	487-490	and	abstract[20]|animal[21]	giv[20]|new[21]	_	_
5-13	491-497	phylum	abstract[20]|animal[21]|person|abstract[25]	giv[20]|new[21]|new|new[25]	_	_
5-14	498-509	Apicomplexa	abstract[20]|animal[21]|abstract[25]	giv[20]|new[21]|new[25]	_	_
5-15	510-514	with	abstract[20]|animal[21]	giv[20]|new[21]	_	_
5-16	515-516	a	abstract[20]|animal[21]|abstract[27]	giv[20]|new[21]|new[27]	coref	8-11[52_27]
5-17	517-524	complex	abstract[20]|animal[21]|abstract[27]	giv[20]|new[21]|new[27]	_	_
5-18	525-529	life	abstract[20]|animal[21]|abstract|abstract[27]	giv[20]|new[21]|new|new[27]	coref	8-12
5-19	530-535	cycle	abstract[20]|animal[21]|abstract[27]	giv[20]|new[21]|new[27]	_	_
5-20	536-537	,	abstract[20]	giv[20]	_	_
5-21	538-547	affecting	abstract[20]	giv[20]	_	_
5-22	548-554	mainly	abstract[20]	giv[20]	_	_
5-23	555-558	the	abstract[20]|object[28]	giv[20]|new[28]	_	_
5-24	559-569	intestinal	abstract[20]|object[28]	giv[20]|new[28]	_	_
5-25	570-575	tract	abstract[20]|object[28]	giv[20]|new[28]	_	_
5-26	576-578	of	abstract[20]|object[28]	giv[20]|new[28]	_	_
5-27	579-583	many	abstract[20]|object[28]|animal[29]	giv[20]|new[28]|new[29]	coref	14-6[89_29]
5-28	584-591	species	abstract[20]|object[28]|animal[29]	giv[20]|new[28]|new[29]	_	_
5-29	592-594	of	abstract[20]|object[28]|animal[29]	giv[20]|new[28]|new[29]	_	_
5-30	595-600	birds	abstract[20]|object[28]|animal[29]|animal	giv[20]|new[28]|new[29]|giv	_	_
5-31	601-602	.	_	_	_	_

#Text=It is of great economic significance in farm animals , especially chickens .
6-1	603-605	It	abstract	giv	coref	7-5
6-2	606-608	is	_	_	_	_
6-3	609-611	of	_	_	_	_
6-4	612-617	great	abstract[32]	new[32]	coref	7-1[36_32]
6-5	618-626	economic	abstract[32]	new[32]	_	_
6-6	627-639	significance	abstract[32]	new[32]	_	_
6-7	640-642	in	abstract[32]	new[32]	_	_
6-8	643-647	farm	abstract[32]|place|animal[34]	new[32]|new|new[34]	appos|coref	6-11[35_34]|17-12[123_0]
6-9	648-655	animals	abstract[32]|animal[34]	new[32]|new[34]	_	_
6-10	656-657	,	_	_	_	_
6-11	658-668	especially	animal[35]	giv[35]	coref	14-37[0_35]
6-12	669-677	chickens	animal[35]	giv[35]	_	_
6-13	678-679	.	_	_	_	_

#Text=The economic significance of coccidiosis is attributed to decreased animal production in terms of poor feed conversion , growth depression and increased mortality ; and the costs involved in treatment and prevention .
7-1	680-683	The	abstract[36]	giv[36]	_	_
7-2	684-692	economic	abstract[36]	giv[36]	_	_
7-3	693-705	significance	abstract[36]	giv[36]	_	_
7-4	706-708	of	abstract[36]	giv[36]	_	_
7-5	709-720	coccidiosis	abstract[36]|abstract	giv[36]|giv	coref	10-7
7-6	721-723	is	_	_	_	_
7-7	724-734	attributed	_	_	_	_
7-8	735-737	to	_	_	_	_
7-9	738-747	decreased	abstract[39]	giv[39]	coref	20-38[150_39]
7-10	748-754	animal	animal|abstract[39]	new|giv[39]	coref	15-15
7-11	755-765	production	abstract[39]	giv[39]	_	_
7-12	766-768	in	_	_	_	_
7-13	769-774	terms	_	_	_	_
7-14	775-777	of	_	_	_	_
7-15	778-782	poor	event[41]	new[41]	_	_
7-16	783-787	feed	substance|event[41]	new|new[41]	coref	11-11
7-17	788-798	conversion	event[41]	new[41]	_	_
7-18	799-800	,	_	_	_	_
7-19	801-807	growth	abstract|abstract[43]	new|new[43]	coref	11-19[71_0]
7-20	808-818	depression	abstract[43]	new[43]	_	_
7-21	819-822	and	_	_	_	_
7-22	823-832	increased	event[44]	new[44]	_	_
7-23	833-842	mortality	event[44]	new[44]	_	_
7-24	843-844	;	_	_	_	_
7-25	845-848	and	_	_	_	_
7-26	849-852	the	abstract[45]	new[45]	coref	10-1[62_45]
7-27	853-858	costs	abstract[45]	new[45]	_	_
7-28	859-867	involved	abstract[45]	new[45]	_	_
7-29	868-870	in	abstract[45]	new[45]	_	_
7-30	871-880	treatment	abstract[45]|abstract	new[45]|new	_	_
7-31	881-884	and	abstract[45]	new[45]	_	_
7-32	885-895	prevention	abstract[45]|abstract	new[45]|new	_	_
7-33	896-897	.	_	_	_	_

#Text=Pathogenesis entails Eimeria invading the intestinal cells as part of the life cycle .
8-1	898-910	Pathogenesis	substance	new	_	_
8-2	911-918	entails	_	_	_	_
8-3	919-926	Eimeria	abstract[49]	giv[49]	coref	14-7[0_49]
8-4	927-935	invading	abstract[49]	giv[49]	_	_
8-5	936-939	the	abstract[49]|plant[50]	giv[49]|new[50]	_	_
8-6	940-950	intestinal	abstract[49]|plant[50]	giv[49]|new[50]	_	_
8-7	951-956	cells	abstract[49]|plant[50]	giv[49]|new[50]	_	_
8-8	957-959	as	abstract[49]	giv[49]	_	_
8-9	960-964	part	abstract[49]	giv[49]	_	_
8-10	965-967	of	abstract[49]	giv[49]	_	_
8-11	968-971	the	abstract[49]|abstract[52]	giv[49]|giv[52]	_	_
8-12	972-976	life	abstract[49]|abstract|abstract[52]	giv[49]|giv|giv[52]	_	_
8-13	977-982	cycle	abstract[49]|abstract[52]	giv[49]|giv[52]	_	_
8-14	983-984	.	_	_	_	_

#Text=The resulting intestinal damage impairs nutrients digestion and absorption , gut barrier function , and ultimately leads to bacterial infections particularly necrotic enteritis .
9-1	985-988	The	event[53]	new[53]	_	_
9-2	989-998	resulting	event[53]	new[53]	_	_
9-3	999-1009	intestinal	event[53]	new[53]	_	_
9-4	1010-1016	damage	event[53]	new[53]	_	_
9-5	1017-1024	impairs	_	_	_	_
9-6	1025-1034	nutrients	substance|abstract[55]	new|new[55]	_	_
9-7	1035-1044	digestion	abstract[55]	new[55]	_	_
9-8	1045-1048	and	_	_	_	_
9-9	1049-1059	absorption	event	new	_	_
9-10	1060-1061	,	_	_	_	_
9-11	1062-1065	gut	abstract|object[58]|abstract[59]	new|new[58]|new[59]	coref	19-15
9-12	1066-1073	barrier	object[58]|abstract[59]	new[58]|new[59]	_	_
9-13	1074-1082	function	abstract[59]	new[59]	_	_
9-14	1083-1084	,	_	_	_	_
9-15	1085-1088	and	_	_	_	_
9-16	1089-1099	ultimately	_	_	_	_
9-17	1100-1105	leads	_	_	_	_
9-18	1106-1108	to	_	_	_	_
9-19	1109-1118	bacterial	event[60]	new[60]	coref	14-20[93_60]
9-20	1119-1129	infections	event[60]	new[60]	_	_
9-21	1130-1142	particularly	substance[61]	new[61]	_	_
9-22	1143-1151	necrotic	substance[61]	new[61]	_	_
9-23	1152-1161	enteritis	substance[61]	new[61]	_	_
9-24	1162-1163	.	_	_	_	_

#Text=The global annual costs inflicted by coccidiosis to commercial poultry have been estimated at 2 billion € .
10-1	1164-1167	The	abstract[62]	giv[62]	_	_
10-2	1168-1174	global	abstract[62]	giv[62]	_	_
10-3	1175-1181	annual	abstract[62]	giv[62]	_	_
10-4	1182-1187	costs	abstract[62]	giv[62]	_	_
10-5	1188-1197	inflicted	abstract[62]	giv[62]	_	_
10-6	1198-1200	by	abstract[62]	giv[62]	_	_
10-7	1201-1212	coccidiosis	abstract[62]|abstract	giv[62]|giv	coref	13-20
10-8	1213-1215	to	abstract[62]	giv[62]	_	_
10-9	1216-1226	commercial	abstract[62]|animal[64]	giv[62]|giv[64]	coref	11-23[0_64]
10-10	1227-1234	poultry	abstract[62]|animal[64]	giv[62]|giv[64]	_	_
10-11	1235-1239	have	_	_	_	_
10-12	1240-1244	been	_	_	_	_
10-13	1245-1254	estimated	_	_	_	_
10-14	1255-1257	at	_	_	_	_
10-15	1258-1259	2	abstract[65]	new[65]	_	_
10-16	1260-1267	billion	abstract[65]	new[65]	_	_
10-17	1268-1269	€	abstract[65]	new[65]	_	_
10-18	1270-1271	.	_	_	_	_

#Text=For the past 5 decades , the use of anti-coccidial feed additives has played a major role in the growth of the poultry industry
11-1	1272-1275	For	_	_	_	_
11-2	1276-1279	the	time[66]	new[66]	coref	19-3[134_66]
11-3	1280-1284	past	time[66]	new[66]	_	_
11-4	1285-1286	5	time[66]	new[66]	_	_
11-5	1287-1294	decades	time[66]	new[66]	_	_
11-6	1295-1296	,	_	_	_	_
11-7	1297-1300	the	event[67]	new[67]	_	_
11-8	1301-1304	use	event[67]	new[67]	_	_
11-9	1305-1307	of	event[67]	new[67]	_	_
11-10	1308-1322	anti-coccidial	event[67]|person[69]	new[67]|new[69]	_	_
11-11	1323-1327	feed	event[67]|substance|person[69]	new[67]|giv|new[69]	coref	20-21
11-12	1328-1337	additives	event[67]|person[69]	new[67]|new[69]	_	_
11-13	1338-1341	has	_	_	_	_
11-14	1342-1348	played	_	_	_	_
11-15	1349-1350	a	abstract[70]	new[70]	_	_
11-16	1351-1356	major	abstract[70]	new[70]	_	_
11-17	1357-1361	role	abstract[70]	new[70]	_	_
11-18	1362-1364	in	abstract[70]	new[70]	_	_
11-19	1365-1368	the	abstract[70]|abstract[71]	new[70]|giv[71]	coref	21-34[0_71]
11-20	1369-1375	growth	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
11-21	1376-1378	of	abstract[70]|abstract[71]	new[70]|giv[71]	_	_
11-22	1379-1382	the	abstract[70]|abstract[71]|abstract[73]	new[70]|giv[71]|new[73]	_	_
11-23	1383-1390	poultry	abstract[70]|abstract[71]|animal|abstract[73]	new[70]|giv[71]|giv|new[73]	coref	12-8
11-24	1391-1399	industry	abstract[70]|abstract[71]|abstract[73]	new[70]|giv[71]|new[73]	_	_

#Text=facilitating increased availability of quality and affordable poultry products to the consumers .
12-1	1400-1412	facilitating	_	_	_	_
12-2	1413-1422	increased	abstract[74]	new[74]	_	_
12-3	1423-1435	availability	abstract[74]	new[74]	_	_
12-4	1436-1438	of	abstract[74]	new[74]	_	_
12-5	1439-1446	quality	abstract[74]|abstract|substance[77]	new[74]|new|new[77]	coref|coref	15-15[105_77]|29-27[243_0]
12-6	1447-1450	and	abstract[74]|substance[77]	new[74]|new[77]	_	_
12-7	1451-1461	affordable	abstract[74]|substance[77]	new[74]|new[77]	_	_
12-8	1462-1469	poultry	abstract[74]|animal|substance[77]	new[74]|giv|new[77]	coref	16-21
12-9	1470-1478	products	abstract[74]|substance[77]	new[74]|new[77]	_	_
12-10	1479-1481	to	abstract[74]|substance[77]	new[74]|new[77]	_	_
12-11	1482-1485	the	abstract[74]|substance[77]|person[78]	new[74]|new[77]|new[78]	_	_
12-12	1486-1495	consumers	abstract[74]|substance[77]|person[78]	new[74]|new[77]|new[78]	_	_
12-13	1496-1497	.	_	_	_	_

#Text=However , some degree of resistance to all anticoccidial drugs , including ionophores which are now the mainstay of coccidiosis control has been reported .
13-1	1498-1505	However	_	_	_	_
13-2	1506-1507	,	_	_	_	_
13-3	1508-1512	some	abstract[79]	new[79]	_	_
13-4	1513-1519	degree	abstract[79]	new[79]	_	_
13-5	1520-1522	of	abstract[79]	new[79]	_	_
13-6	1523-1533	resistance	abstract[79]|abstract[80]	new[79]|new[80]	coref	16-17[117_80]
13-7	1534-1536	to	abstract[79]|abstract[80]	new[79]|new[80]	_	_
13-8	1537-1540	all	abstract[79]|abstract[80]|substance[81]	new[79]|new[80]|new[81]	coref	14-10[90_81]
13-9	1541-1554	anticoccidial	abstract[79]|abstract[80]|substance[81]	new[79]|new[80]|new[81]	_	_
13-10	1555-1560	drugs	abstract[79]|abstract[80]|substance[81]	new[79]|new[80]|new[81]	_	_
13-11	1561-1562	,	abstract[79]|abstract[80]|substance[81]	new[79]|new[80]|new[81]	_	_
13-12	1563-1572	including	abstract[79]|abstract[80]|substance[81]	new[79]|new[80]|new[81]	_	_
13-13	1573-1583	ionophores	abstract[79]|abstract[80]|substance[81]|substance[82]	new[79]|new[80]|new[81]|new[82]	_	_
13-14	1584-1589	which	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-15	1590-1593	are	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-16	1594-1597	now	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-17	1598-1601	the	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-18	1602-1610	mainstay	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-19	1611-1613	of	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]	new[79]|new[80]|new[81]|new[82]|new[83]	_	_
13-20	1614-1625	coccidiosis	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]|abstract|abstract[85]	new[79]|new[80]|new[81]|new[82]|new[83]|giv|new[85]	coref|coref	15-27[109_85]|16-3
13-21	1626-1633	control	abstract[79]|abstract[80]|substance[81]|substance[82]|time[83]|abstract[85]	new[79]|new[80]|new[81]|new[82]|new[83]|new[85]	_	_
13-22	1634-1637	has	_	_	_	_
13-23	1638-1642	been	_	_	_	_
13-24	1643-1651	reported	_	_	_	_
13-25	1652-1653	.	_	_	_	_

#Text=Concerns over the development of resistant Eimeria species to existing anticoccidial drugs and restrictive use of antibiotics to control secondary bacterial infections further stresses the urgent need to explore alternative strategies for maintaining intestinal functionality in chickens .
14-1	1654-1662	Concerns	abstract[86]	new[86]	coref	15-4[101_86]
14-2	1663-1667	over	abstract[86]	new[86]	_	_
14-3	1668-1671	the	abstract[86]|event[87]	new[86]|new[87]	_	_
14-4	1672-1683	development	abstract[86]|event[87]	new[86]|new[87]	_	_
14-5	1684-1686	of	abstract[86]|event[87]	new[86]|new[87]	_	_
14-6	1687-1696	resistant	abstract[86]|event[87]|animal[89]	new[86]|new[87]|giv[89]	_	_
14-7	1697-1704	Eimeria	abstract[86]|event[87]|abstract|animal[89]	new[86]|new[87]|giv|giv[89]	_	_
14-8	1705-1712	species	abstract[86]|event[87]|animal[89]	new[86]|new[87]|giv[89]	_	_
14-9	1713-1715	to	abstract[86]|event[87]	new[86]|new[87]	_	_
14-10	1716-1724	existing	abstract[86]|event[87]|substance[90]	new[86]|new[87]|giv[90]	_	_
14-11	1725-1738	anticoccidial	abstract[86]|event[87]|substance[90]	new[86]|new[87]|giv[90]	_	_
14-12	1739-1744	drugs	abstract[86]|event[87]|substance[90]	new[86]|new[87]|giv[90]	_	_
14-13	1745-1748	and	_	_	_	_
14-14	1749-1760	restrictive	event[91]	new[91]	_	_
14-15	1761-1764	use	event[91]	new[91]	_	_
14-16	1765-1767	of	event[91]	new[91]	_	_
14-17	1768-1779	antibiotics	event[91]|substance	new[91]|new	coref	20-4
14-18	1780-1782	to	event[91]	new[91]	_	_
14-19	1783-1790	control	event[91]	new[91]	_	_
14-20	1791-1800	secondary	event[91]|event[93]	new[91]|giv[93]	_	_
14-21	1801-1810	bacterial	event[91]|event[93]	new[91]|giv[93]	_	_
14-22	1811-1821	infections	event[91]|event[93]	new[91]|giv[93]	_	_
14-23	1822-1829	further	_	_	_	_
14-24	1830-1838	stresses	_	_	_	_
14-25	1839-1842	the	abstract[94]	new[94]	coref	15-18[106_94]
14-26	1843-1849	urgent	abstract[94]	new[94]	_	_
14-27	1850-1854	need	abstract[94]	new[94]	_	_
14-28	1855-1857	to	abstract[94]	new[94]	_	_
14-29	1858-1865	explore	abstract[94]	new[94]	_	_
14-30	1866-1877	alternative	abstract[94]|abstract[95]	new[94]|new[95]	coref	15-24[108_95]
14-31	1878-1888	strategies	abstract[94]|abstract[95]	new[94]|new[95]	_	_
14-32	1889-1892	for	abstract[94]|abstract[95]	new[94]|new[95]	_	_
14-33	1893-1904	maintaining	abstract[94]|abstract[95]	new[94]|new[95]	_	_
14-34	1905-1915	intestinal	abstract[94]|abstract[95]|abstract[96]	new[94]|new[95]|new[96]	_	_
14-35	1916-1929	functionality	abstract[94]|abstract[95]|abstract[96]	new[94]|new[95]|new[96]	_	_
14-36	1930-1932	in	abstract[94]|abstract[95]	new[94]|new[95]	_	_
14-37	1933-1941	chickens	abstract[94]|abstract[95]|animal	new[94]|new[95]|giv	coref	18-5
14-38	1942-1943	.	_	_	_	_

#Text=In addition , serious public health and food safety concerns regarding drug residues in animal products highlight the need for researchers to develop alternative strategies for the control of parasitic problems .
15-1	1944-1946	In	_	_	_	_
15-2	1947-1955	addition	_	_	_	_
15-3	1956-1957	,	_	_	_	_
15-4	1958-1965	serious	abstract[98]|abstract[101]	new[98]|giv[101]	coref	32-31[275_98]
15-5	1966-1972	public	abstract[98]|abstract[101]	new[98]|giv[101]	_	_
15-6	1973-1979	health	abstract[98]|abstract[101]	new[98]|giv[101]	_	_
15-7	1980-1983	and	abstract[101]	giv[101]	_	_
15-8	1984-1988	food	substance|abstract[100]|abstract[101]	new|new[100]|giv[101]	_	_
15-9	1989-1995	safety	abstract[100]|abstract[101]	new[100]|giv[101]	_	_
15-10	1996-2004	concerns	abstract[101]	giv[101]	_	_
15-11	2005-2014	regarding	abstract[101]	giv[101]	_	_
15-12	2015-2019	drug	abstract[101]|substance|substance[103]	giv[101]|new|new[103]	coref	16-18
15-13	2020-2028	residues	abstract[101]|substance[103]	giv[101]|new[103]	_	_
15-14	2029-2031	in	abstract[101]|substance[103]	giv[101]|new[103]	_	_
15-15	2032-2038	animal	abstract[101]|substance[103]|animal|substance[105]	giv[101]|new[103]|giv|giv[105]	_	_
15-16	2039-2047	products	abstract[101]|substance[103]|substance[105]	giv[101]|new[103]|giv[105]	_	_
15-17	2048-2057	highlight	_	_	_	_
15-18	2058-2061	the	abstract[106]	giv[106]	_	_
15-19	2062-2066	need	abstract[106]	giv[106]	_	_
15-20	2067-2070	for	abstract[106]	giv[106]	_	_
15-21	2071-2082	researchers	abstract[106]|person	giv[106]|new	_	_
15-22	2083-2085	to	abstract[106]	giv[106]	_	_
15-23	2086-2093	develop	abstract[106]	giv[106]	_	_
15-24	2094-2105	alternative	abstract[106]|abstract[108]	giv[106]|giv[108]	ana	17-3[0_108]
15-25	2106-2116	strategies	abstract[106]|abstract[108]	giv[106]|giv[108]	_	_
15-26	2117-2120	for	abstract[106]|abstract[108]	giv[106]|giv[108]	_	_
15-27	2121-2124	the	abstract[106]|abstract[108]|abstract[109]	giv[106]|giv[108]|giv[109]	coref	16-12[115_109]
15-28	2125-2132	control	abstract[106]|abstract[108]|abstract[109]	giv[106]|giv[108]|giv[109]	_	_
15-29	2133-2135	of	abstract[106]|abstract[108]|abstract[109]	giv[106]|giv[108]|giv[109]	_	_
15-30	2136-2145	parasitic	abstract[106]|abstract[108]|abstract[109]|abstract[110]	giv[106]|giv[108]|giv[109]|new[110]	_	_
15-31	2146-2154	problems	abstract[106]|abstract[108]|abstract[109]|abstract[110]	giv[106]|giv[108]|giv[109]|new[110]	_	_
15-32	2155-2156	.	_	_	_	_

#Text=Vaccines for coccidiosis have been reported as an effective tool for disease control and to ameliorate anticoccidial drug resistance in poultry .
16-1	2157-2165	Vaccines	substance[111]	new[111]	_	_
16-2	2166-2169	for	substance[111]	new[111]	_	_
16-3	2170-2181	coccidiosis	substance[111]|abstract	new[111]|giv	coref	16-12
16-4	2182-2186	have	_	_	_	_
16-5	2187-2191	been	_	_	_	_
16-6	2192-2200	reported	_	_	_	_
16-7	2201-2203	as	_	_	_	_
16-8	2204-2206	an	abstract[113]	new[113]	_	_
16-9	2207-2216	effective	abstract[113]	new[113]	_	_
16-10	2217-2221	tool	abstract[113]	new[113]	_	_
16-11	2222-2225	for	abstract[113]	new[113]	_	_
16-12	2226-2233	disease	abstract[113]|abstract|abstract[115]	new[113]|giv|giv[115]	coref	21-31
16-13	2234-2241	control	abstract[113]|abstract[115]	new[113]|giv[115]	_	_
16-14	2242-2245	and	_	_	_	_
16-15	2246-2248	to	_	_	_	_
16-16	2249-2259	ameliorate	_	_	_	_
16-17	2260-2273	anticoccidial	abstract[117]	giv[117]	_	_
16-18	2274-2278	drug	substance|abstract[117]	giv|giv[117]	_	_
16-19	2279-2289	resistance	abstract[117]	giv[117]	_	_
16-20	2290-2292	in	_	_	_	_
16-21	2293-2300	poultry	animal	giv	coref	20-38
16-22	2301-2302	.	_	_	_	_

#Text=However , their efficacy depends greatly on the management strategies in a farm .
17-1	2303-2310	However	_	_	_	_
17-2	2311-2312	,	_	_	_	_
17-3	2313-2318	their	abstract|abstract[120]	giv|new[120]	coref|coref	17-8[122_0]|30-3[244_120]
17-4	2319-2327	efficacy	abstract[120]	new[120]	_	_
17-5	2328-2335	depends	_	_	_	_
17-6	2336-2343	greatly	_	_	_	_
17-7	2344-2346	on	_	_	_	_
17-8	2347-2350	the	abstract[122]	giv[122]	_	_
17-9	2351-2361	management	person|abstract[122]	new|giv[122]	coref	31-19
17-10	2362-2372	strategies	abstract[122]	giv[122]	_	_
17-11	2373-2375	in	abstract[122]	giv[122]	_	_
17-12	2376-2377	a	abstract[122]|place[123]	giv[122]|giv[123]	_	_
17-13	2378-2382	farm	abstract[122]|place[123]	giv[122]|giv[123]	_	_
17-14	2383-2384	.	_	_	_	_

#Text=The digestive tract of animals harbors a great number of living and metabolizing microorganisms ( microbiota ) , that not only influence physiological functions of the host , but are also considered fundamental for a proper development of several vital traits , including immune system .
18-1	2385-2388	The	object[124]	new[124]	_	_
18-2	2389-2398	digestive	object[124]	new[124]	_	_
18-3	2399-2404	tract	object[124]	new[124]	_	_
18-4	2405-2407	of	object[124]	new[124]	_	_
18-5	2408-2415	animals	object[124]|animal	new[124]|giv	coref	19-18
18-6	2416-2423	harbors	_	_	_	_
18-7	2424-2425	a	abstract[126]	new[126]	_	_
18-8	2426-2431	great	abstract[126]	new[126]	_	_
18-9	2432-2438	number	abstract[126]	new[126]	_	_
18-10	2439-2441	of	abstract[126]	new[126]	_	_
18-11	2442-2448	living	abstract[126]|animal[127]	new[126]|new[127]	appos	18-16[0_127]
18-12	2449-2452	and	abstract[126]|animal[127]	new[126]|new[127]	_	_
18-13	2453-2465	metabolizing	abstract[126]|animal[127]	new[126]|new[127]	_	_
18-14	2466-2480	microorganisms	abstract[126]|animal[127]	new[126]|new[127]	_	_
18-15	2481-2482	(	_	_	_	_
18-16	2483-2493	microbiota	animal	giv	_	_
18-17	2494-2495	)	_	_	_	_
18-18	2496-2497	,	_	_	_	_
18-19	2498-2502	that	_	_	_	_
18-20	2503-2506	not	_	_	_	_
18-21	2507-2511	only	_	_	_	_
18-22	2512-2521	influence	_	_	_	_
18-23	2522-2535	physiological	abstract[129]	new[129]	_	_
18-24	2536-2545	functions	abstract[129]	new[129]	_	_
18-25	2546-2548	of	abstract[129]	new[129]	_	_
18-26	2549-2552	the	abstract[129]|animal[130]	new[129]|new[130]	coref	29-18[239_130]
18-27	2553-2557	host	abstract[129]|animal[130]	new[129]|new[130]	_	_
18-28	2558-2559	,	_	_	_	_
18-29	2560-2563	but	_	_	_	_
18-30	2564-2567	are	_	_	_	_
18-31	2568-2572	also	_	_	_	_
18-32	2573-2583	considered	_	_	_	_
18-33	2584-2595	fundamental	_	_	_	_
18-34	2596-2599	for	_	_	_	_
18-35	2600-2601	a	event[131]	new[131]	coref	26-16[201_131]
18-36	2602-2608	proper	event[131]	new[131]	_	_
18-37	2609-2620	development	event[131]	new[131]	_	_
18-38	2621-2623	of	event[131]	new[131]	_	_
18-39	2624-2631	several	event[131]|abstract[132]	new[131]|new[132]	coref	32-24[271_132]
18-40	2632-2637	vital	event[131]|abstract[132]	new[131]|new[132]	_	_
18-41	2638-2644	traits	event[131]|abstract[132]	new[131]|new[132]	_	_
18-42	2645-2646	,	event[131]|abstract[132]	new[131]|new[132]	_	_
18-43	2647-2656	including	event[131]|abstract[132]	new[131]|new[132]	_	_
18-44	2657-2663	immune	event[131]|abstract[132]|abstract[133]	new[131]|new[132]|new[133]	coref	21-18[162_133]
18-45	2664-2670	system	event[131]|abstract[132]|abstract[133]	new[131]|new[132]|new[133]	_	_
18-46	2671-2672	.	_	_	_	_

#Text=Thus , the past decades , have seen much effort going into optimizing the gut microbiota of chickens using dietary interventions .
19-1	2673-2677	Thus	_	_	_	_
19-2	2678-2679	,	_	_	_	_
19-3	2680-2683	the	time[134]	giv[134]	_	_
19-4	2684-2688	past	time[134]	giv[134]	_	_
19-5	2689-2696	decades	time[134]	giv[134]	_	_
19-6	2697-2698	,	_	_	_	_
19-7	2699-2703	have	_	_	_	_
19-8	2704-2708	seen	_	_	_	_
19-9	2709-2713	much	abstract[135]	new[135]	_	_
19-10	2714-2720	effort	abstract[135]	new[135]	_	_
19-11	2721-2726	going	abstract[135]	new[135]	_	_
19-12	2727-2731	into	_	_	_	_
19-13	2732-2742	optimizing	_	_	_	_
19-14	2743-2746	the	substance[137]	new[137]	coref	28-34[233_137]
19-15	2747-2750	gut	abstract|substance[137]	giv|new[137]	coref	27-38
19-16	2751-2761	microbiota	substance[137]	new[137]	_	_
19-17	2762-2764	of	substance[137]	new[137]	_	_
19-18	2765-2773	chickens	substance[137]|animal	new[137]|giv	coref	20-26
19-19	2774-2779	using	_	_	_	_
19-20	2780-2787	dietary	event[139]	new[139]	_	_
19-21	2788-2801	interventions	event[139]	new[139]	_	_
19-22	2802-2803	.	_	_	_	_

#Text=Although use of antibiotics at subtherapeutic levels has been the most popular and perhaps the most effective strategy to enhance feed efficiency and to keep animals healthy , the approach is no longer a feasible tool for poultry production performance enhancement due to its ban by the EU in 2006 .
20-1	2804-2812	Although	_	_	_	_
20-2	2813-2816	use	abstract[140]	new[140]	coref	20-10[143_140]
20-3	2817-2819	of	abstract[140]	new[140]	_	_
20-4	2820-2831	antibiotics	abstract[140]|substance	new[140]|giv	coref	21-41
20-5	2832-2834	at	abstract[140]	new[140]	_	_
20-6	2835-2849	subtherapeutic	abstract[140]|abstract[142]	new[140]|new[142]	_	_
20-7	2850-2856	levels	abstract[140]|abstract[142]	new[140]|new[142]	_	_
20-8	2857-2860	has	_	_	_	_
20-9	2861-2865	been	_	_	_	_
20-10	2866-2869	the	abstract[143]	giv[143]	_	_
20-11	2870-2874	most	abstract[143]	giv[143]	_	_
20-12	2875-2882	popular	abstract[143]	giv[143]	_	_
20-13	2883-2886	and	abstract[143]	giv[143]	_	_
20-14	2887-2894	perhaps	abstract[143]	giv[143]	_	_
20-15	2895-2898	the	abstract[143]	giv[143]	_	_
20-16	2899-2903	most	abstract[143]	giv[143]	_	_
20-17	2904-2913	effective	abstract[143]	giv[143]	_	_
20-18	2914-2922	strategy	abstract[143]	giv[143]	_	_
20-19	2923-2925	to	abstract[143]	giv[143]	_	_
20-20	2926-2933	enhance	abstract[143]	giv[143]	_	_
20-21	2934-2938	feed	abstract[143]|substance|abstract[145]	giv[143]|giv|new[145]	_	_
20-22	2939-2949	efficiency	abstract[143]|abstract[145]	giv[143]|new[145]	_	_
20-23	2950-2953	and	abstract[143]	giv[143]	_	_
20-24	2954-2956	to	abstract[143]	giv[143]	_	_
20-25	2957-2961	keep	abstract[143]	giv[143]	_	_
20-26	2962-2969	animals	abstract[143]|animal	giv[143]|giv	coref	24-17[190_0]
20-27	2970-2977	healthy	abstract[143]	giv[143]	_	_
20-28	2978-2979	,	_	_	_	_
20-29	2980-2983	the	abstract[147]	new[147]	coref	20-33[148_147]
20-30	2984-2992	approach	abstract[147]	new[147]	_	_
20-31	2993-2995	is	_	_	_	_
20-32	2996-2998	no	_	_	_	_
20-33	2999-3005	longer	abstract[148]	giv[148]	ana	20-44[0_148]
20-34	3006-3007	a	abstract[148]	giv[148]	_	_
20-35	3008-3016	feasible	abstract[148]	giv[148]	_	_
20-36	3017-3021	tool	abstract[148]	giv[148]	_	_
20-37	3022-3025	for	abstract[148]	giv[148]	_	_
20-38	3026-3033	poultry	abstract[148]|animal|abstract[150]|abstract[152]	giv[148]|giv|giv[150]|new[152]	_	_
20-39	3034-3044	production	abstract[148]|abstract[150]|abstract[152]	giv[148]|giv[150]|new[152]	_	_
20-40	3045-3056	performance	abstract[148]|abstract|abstract[152]	giv[148]|new|new[152]	coref	21-34[167_0]
20-41	3057-3068	enhancement	abstract[148]|abstract[152]	giv[148]|new[152]	_	_
20-42	3069-3072	due	abstract[148]	giv[148]	_	_
20-43	3073-3075	to	abstract[148]	giv[148]	_	_
20-44	3076-3079	its	abstract[148]|abstract|event[154]	giv[148]|giv|new[154]	_	_
20-45	3080-3083	ban	abstract[148]|event[154]	giv[148]|new[154]	_	_
20-46	3084-3086	by	abstract[148]|event[154]	giv[148]|new[154]	_	_
20-47	3087-3090	the	abstract[148]|event[154]|organization[155]	giv[148]|new[154]|new[155]	_	_
20-48	3091-3093	EU	abstract[148]|event[154]|organization[155]	giv[148]|new[154]|new[155]	_	_
20-49	3094-3096	in	abstract[148]|event[154]	giv[148]|new[154]	_	_
20-50	3097-3101	2006	abstract[148]|event[154]|time	giv[148]|new[154]|new	_	_
20-51	3102-3103	.	_	_	_	_

#Text=Incorporation of immunobiotics , particularly lactic acid bacteria is thought to be useful as immunomodulators to stimulate the gut-associated immune system in neonatal chicks , and thereby protect them from disease without decreasing growth performance as a possible substitution of antibiotics .
21-1	3104-3117	Incorporation	abstract[157]	new[157]	_	_
21-2	3118-3120	of	abstract[157]	new[157]	_	_
21-3	3121-3134	immunobiotics	abstract[157]|abstract	new[157]|new	_	_
21-4	3135-3136	,	_	_	_	_
21-5	3137-3149	particularly	plant[160]	new[160]	_	_
21-6	3150-3156	lactic	substance[159]|plant[160]	new[159]|new[160]	_	_
21-7	3157-3161	acid	substance[159]|plant[160]	new[159]|new[160]	_	_
21-8	3162-3170	bacteria	plant[160]	new[160]	_	_
21-9	3171-3173	is	_	_	_	_
21-10	3174-3181	thought	_	_	_	_
21-11	3182-3184	to	_	_	_	_
21-12	3185-3187	be	_	_	_	_
21-13	3188-3194	useful	_	_	_	_
21-14	3195-3197	as	_	_	_	_
21-15	3198-3214	immunomodulators	abstract	new	ana	21-29
21-16	3215-3217	to	_	_	_	_
21-17	3218-3227	stimulate	_	_	_	_
21-18	3228-3231	the	abstract[162]	giv[162]	_	_
21-19	3232-3246	gut-associated	abstract[162]	giv[162]	_	_
21-20	3247-3253	immune	abstract[162]	giv[162]	_	_
21-21	3254-3260	system	abstract[162]	giv[162]	_	_
21-22	3261-3263	in	_	_	_	_
21-23	3264-3272	neonatal	animal[163]	new[163]	coref	27-41[219_163]
21-24	3273-3279	chicks	animal[163]	new[163]	_	_
21-25	3280-3281	,	_	_	_	_
21-26	3282-3285	and	_	_	_	_
21-27	3286-3293	thereby	_	_	_	_
21-28	3294-3301	protect	_	_	_	_
21-29	3302-3306	them	abstract	giv	_	_
21-30	3307-3311	from	_	_	_	_
21-31	3312-3319	disease	abstract	giv	coref	32-39
21-32	3320-3327	without	_	_	_	_
21-33	3328-3338	decreasing	_	_	_	_
21-34	3339-3345	growth	abstract|abstract[167]	giv|giv[167]	coref|coref	29-25[0_167]|32-21
21-35	3346-3357	performance	abstract[167]	giv[167]	_	_
21-36	3358-3360	as	_	_	_	_
21-37	3361-3362	a	abstract[168]	new[168]	_	_
21-38	3363-3371	possible	abstract[168]	new[168]	_	_
21-39	3372-3384	substitution	abstract[168]	new[168]	_	_
21-40	3385-3387	of	abstract[168]	new[168]	_	_
21-41	3388-3399	antibiotics	abstract[168]|substance	new[168]|giv	_	_
21-42	3400-3401	.	_	_	_	_

#Text=Prebiotics , which are defined as non-digestible oligosaccharides , are also potent modulators of the intestinal microflora .
22-1	3402-3412	Prebiotics	substance[170]	new[170]	coref	22-12[172_170]
22-2	3413-3414	,	substance[170]	new[170]	_	_
22-3	3415-3420	which	substance[170]	new[170]	_	_
22-4	3421-3424	are	substance[170]	new[170]	_	_
22-5	3425-3432	defined	substance[170]	new[170]	_	_
22-6	3433-3435	as	substance[170]	new[170]	_	_
22-7	3436-3450	non-digestible	substance[170]|substance[171]	new[170]|new[171]	_	_
22-8	3451-3467	oligosaccharides	substance[170]|substance[171]	new[170]|new[171]	_	_
22-9	3468-3469	,	_	_	_	_
22-10	3470-3473	are	_	_	_	_
22-11	3474-3478	also	_	_	_	_
22-12	3479-3485	potent	substance[172]	giv[172]	coref	27-29[0_172]
22-13	3486-3496	modulators	substance[172]	giv[172]	_	_
22-14	3497-3499	of	substance[172]	giv[172]	_	_
22-15	3500-3503	the	substance[172]|substance[173]	giv[172]|new[173]	coref	27-38[218_173]
22-16	3504-3514	intestinal	substance[172]|substance[173]	giv[172]|new[173]	_	_
22-17	3515-3525	microflora	substance[172]|substance[173]	giv[172]|new[173]	_	_
22-18	3526-3527	.	_	_	_	_

#Text=For instance , addition of prebiotic mannanoligosaccharides ( MOS ) to the diet of broilers reduced the severity of the infection due to either E. tenella alone or a mixture of E. acervulina , E. maxima , and E. tenella .
23-1	3528-3531	For	_	_	_	_
23-2	3532-3540	instance	_	_	_	_
23-3	3541-3542	,	_	_	_	_
23-4	3543-3551	addition	event[174]	new[174]	_	_
23-5	3552-3554	of	event[174]	new[174]	_	_
23-6	3555-3564	prebiotic	event[174]|substance|animal[176]	new[174]|new|new[176]	_	_
23-7	3565-3587	mannanoligosaccharides	event[174]|animal[176]	new[174]|new[176]	_	_
23-8	3588-3589	(	event[174]	new[174]	_	_
23-9	3590-3593	MOS	event[174]|substance	new[174]|new	_	_
23-10	3594-3595	)	event[174]	new[174]	_	_
23-11	3596-3598	to	event[174]	new[174]	_	_
23-12	3599-3602	the	event[174]|substance[178]	new[174]|new[178]	coref	27-11[209_178]
23-13	3603-3607	diet	event[174]|substance[178]	new[174]|new[178]	_	_
23-14	3608-3610	of	event[174]|substance[178]	new[174]|new[178]	_	_
23-15	3611-3619	broilers	event[174]|substance[178]|substance	new[174]|new[178]|new	_	_
23-16	3620-3627	reduced	_	_	_	_
23-17	3628-3631	the	abstract[180]	new[180]	_	_
23-18	3632-3640	severity	abstract[180]	new[180]	_	_
23-19	3641-3643	of	abstract[180]	new[180]	_	_
23-20	3644-3647	the	abstract[180]|event[181]	new[180]|new[181]	coref	32-37[278_181]
23-21	3648-3657	infection	abstract[180]|event[181]	new[180]|new[181]	_	_
23-22	3658-3661	due	abstract[180]|event[181]	new[180]|new[181]	_	_
23-23	3662-3664	to	abstract[180]|event[181]	new[180]|new[181]	_	_
23-24	3665-3671	either	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	coref	23-32[0_182]
23-25	3672-3674	E.	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-26	3675-3682	tenella	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-27	3683-3688	alone	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-28	3689-3691	or	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-29	3692-3693	a	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-30	3694-3701	mixture	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-31	3702-3704	of	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-32	3705-3707	E.	abstract[180]|event[181]|person[182]|person	new[180]|new[181]|new[182]|giv	coref	23-35
23-33	3708-3718	acervulina	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-34	3719-3720	,	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-35	3721-3723	E.	abstract[180]|event[181]|person[182]|person|object[185]	new[180]|new[181]|new[182]|giv|new[185]	coref	23-39
23-36	3724-3730	maxima	abstract[180]|event[181]|person[182]|object[185]	new[180]|new[181]|new[182]|new[185]	_	_
23-37	3731-3732	,	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-38	3733-3736	and	abstract[180]|event[181]|person[182]	new[180]|new[181]|new[182]	_	_
23-39	3737-3739	E.	abstract[180]|event[181]|person[182]|person|animal[187]	new[180]|new[181]|new[182]|giv|new[187]	_	_
23-40	3740-3747	tenella	abstract[180]|event[181]|person[182]|animal[187]	new[180]|new[181]|new[182]|new[187]	_	_
23-41	3748-3749	.	_	_	_	_

#Text=However , for the bioactives to be effective , these compounds have to be administered to the animals under fully controlled conditions and as early as possible .
24-1	3750-3757	However	_	_	_	_
24-2	3758-3759	,	_	_	_	_
24-3	3760-3763	for	_	_	_	_
24-4	3764-3767	the	substance[188]	new[188]	_	_
24-5	3768-3778	bioactives	substance[188]	new[188]	_	_
24-6	3779-3781	to	_	_	_	_
24-7	3782-3784	be	_	_	_	_
24-8	3785-3794	effective	_	_	_	_
24-9	3795-3796	,	_	_	_	_
24-10	3797-3802	these	substance[189]	new[189]	_	_
24-11	3803-3812	compounds	substance[189]	new[189]	_	_
24-12	3813-3817	have	_	_	_	_
24-13	3818-3820	to	_	_	_	_
24-14	3821-3823	be	_	_	_	_
24-15	3824-3836	administered	_	_	_	_
24-16	3837-3839	to	_	_	_	_
24-17	3840-3843	the	animal[190]	giv[190]	coref	25-9[0_190]
24-18	3844-3851	animals	animal[190]	giv[190]	_	_
24-19	3852-3857	under	_	_	_	_
24-20	3858-3863	fully	abstract[191]	new[191]	coref	30-15[247_191]
24-21	3864-3874	controlled	abstract[191]	new[191]	_	_
24-22	3875-3885	conditions	abstract[191]	new[191]	_	_
24-23	3886-3889	and	_	_	_	_
24-24	3890-3892	as	_	_	_	_
24-25	3893-3898	early	_	_	_	_
24-26	3899-3901	as	_	_	_	_
24-27	3902-3910	possible	_	_	_	_
24-28	3911-3912	.	_	_	_	_

#Text=An innovative method for introducing bioactive substances into chickens is the in ovo injection into eggs intended for hatching .
25-1	3913-3915	An	event[192]	new[192]	coref	25-11[195_192]
25-2	3916-3926	innovative	event[192]	new[192]	_	_
25-3	3927-3933	method	event[192]	new[192]	_	_
25-4	3934-3937	for	event[192]	new[192]	_	_
25-5	3938-3949	introducing	event[192]	new[192]	_	_
25-6	3950-3959	bioactive	event[192]|substance[193]	new[192]|new[193]	coref	26-19[202_193]
25-7	3960-3970	substances	event[192]|substance[193]	new[192]|new[193]	_	_
25-8	3971-3975	into	event[192]	new[192]	_	_
25-9	3976-3984	chickens	event[192]|animal	new[192]|giv	coref	30-24[251_0]
25-10	3985-3987	is	_	_	_	_
25-11	3988-3991	the	event[195]	giv[195]	ana	26-1[0_195]
25-12	3992-3994	in	event[195]	giv[195]	_	_
25-13	3995-3998	ovo	event[195]	giv[195]	_	_
25-14	3999-4008	injection	event[195]	giv[195]	_	_
25-15	4009-4013	into	event[195]	giv[195]	_	_
25-16	4014-4018	eggs	event[195]|object[196]	giv[195]|new[196]	_	_
25-17	4019-4027	intended	event[195]|object[196]	giv[195]|new[196]	_	_
25-18	4028-4031	for	event[195]|object[196]	giv[195]|new[196]	_	_
25-19	4032-4040	hatching	event[195]|object[196]	giv[195]|new[196]	_	_
25-20	4041-4042	.	_	_	_	_

#Text=This is a technique that is based on the introduction on the appropriate day of embryonic development of bioactive substances into the air chamber of the egg or directly into the developing embryo .
26-1	4043-4047	This	event	giv	coref	26-3[198_0]
26-2	4048-4050	is	_	_	_	_
26-3	4051-4052	a	event[198]	giv[198]	coref	27-1[207_198]
26-4	4053-4062	technique	event[198]	giv[198]	_	_
26-5	4063-4067	that	event[198]	giv[198]	_	_
26-6	4068-4070	is	event[198]	giv[198]	_	_
26-7	4071-4076	based	event[198]	giv[198]	_	_
26-8	4077-4079	on	event[198]	giv[198]	_	_
26-9	4080-4083	the	event[198]|event[199]	giv[198]|new[199]	_	_
26-10	4084-4096	introduction	event[198]|event[199]	giv[198]|new[199]	_	_
26-11	4097-4099	on	event[198]|event[199]	giv[198]|new[199]	_	_
26-12	4100-4103	the	event[198]|event[199]|time[200]	giv[198]|new[199]|new[200]	_	_
26-13	4104-4115	appropriate	event[198]|event[199]|time[200]	giv[198]|new[199]|new[200]	_	_
26-14	4116-4119	day	event[198]|event[199]|time[200]	giv[198]|new[199]|new[200]	_	_
26-15	4120-4122	of	event[198]|event[199]|time[200]	giv[198]|new[199]|new[200]	_	_
26-16	4123-4132	embryonic	event[198]|event[199]|time[200]|event[201]	giv[198]|new[199]|new[200]|giv[201]	coref	27-22[0_201]
26-17	4133-4144	development	event[198]|event[199]|time[200]|event[201]	giv[198]|new[199]|new[200]|giv[201]	_	_
26-18	4145-4147	of	event[198]|event[199]	giv[198]|new[199]	_	_
26-19	4148-4157	bioactive	event[198]|event[199]|substance[202]	giv[198]|new[199]|giv[202]	_	_
26-20	4158-4168	substances	event[198]|event[199]|substance[202]	giv[198]|new[199]|giv[202]	_	_
26-21	4169-4173	into	event[198]	giv[198]	_	_
26-22	4174-4177	the	event[198]|place[204]	giv[198]|new[204]	_	_
26-23	4178-4181	air	event[198]|abstract|place[204]	giv[198]|new|new[204]	coref	28-21
26-24	4182-4189	chamber	event[198]|place[204]	giv[198]|new[204]	_	_
26-25	4190-4192	of	event[198]|place[204]	giv[198]|new[204]	_	_
26-26	4193-4196	the	event[198]|place[204]|object[205]	giv[198]|new[204]|new[205]	coref	28-26[0_205]
26-27	4197-4200	egg	event[198]|place[204]|object[205]	giv[198]|new[204]|new[205]	_	_
26-28	4201-4203	or	_	_	_	_
26-29	4204-4212	directly	animal[206]	new[206]	_	_
26-30	4213-4217	into	animal[206]	new[206]	_	_
26-31	4218-4221	the	animal[206]	new[206]	_	_
26-32	4222-4232	developing	animal[206]	new[206]	_	_
26-33	4233-4239	embryo	animal[206]	new[206]	_	_
26-34	4240-4241	.	_	_	_	_

#Text=This method allows for a precise and uniform delivery of the bioactive substance to all embryos at an early stage of development , which unifies the effects of prebiotics across the flock and ensures proper development of gut microflora in all chicks .
27-1	4242-4246	This	event[207]	giv[207]	coref	28-13[222_207]
27-2	4247-4253	method	event[207]	giv[207]	_	_
27-3	4254-4260	allows	_	_	_	_
27-4	4261-4264	for	_	_	_	_
27-5	4265-4266	a	event[208]	new[208]	_	_
27-6	4267-4274	precise	event[208]	new[208]	_	_
27-7	4275-4278	and	event[208]	new[208]	_	_
27-8	4279-4286	uniform	event[208]	new[208]	_	_
27-9	4287-4295	delivery	event[208]	new[208]	_	_
27-10	4296-4298	of	event[208]	new[208]	_	_
27-11	4299-4302	the	event[208]|substance[209]	new[208]|giv[209]	_	_
27-12	4303-4312	bioactive	event[208]|substance[209]	new[208]|giv[209]	_	_
27-13	4313-4322	substance	event[208]|substance[209]	new[208]|giv[209]	_	_
27-14	4323-4325	to	event[208]|substance[209]	new[208]|giv[209]	_	_
27-15	4326-4329	all	event[208]|substance[209]|animal[210]	new[208]|giv[209]|new[210]	_	_
27-16	4330-4337	embryos	event[208]|substance[209]|animal[210]	new[208]|giv[209]|new[210]	_	_
27-17	4338-4340	at	event[208]	new[208]	_	_
27-18	4341-4343	an	event[208]|time[211]	new[208]|new[211]	_	_
27-19	4344-4349	early	event[208]|time[211]	new[208]|new[211]	_	_
27-20	4350-4355	stage	event[208]|time[211]	new[208]|new[211]	_	_
27-21	4356-4358	of	event[208]|time[211]	new[208]|new[211]	_	_
27-22	4359-4370	development	event[208]|time[211]|event	new[208]|new[211]|giv	_	_
27-23	4371-4372	,	event[208]	new[208]	_	_
27-24	4373-4378	which	event[208]	new[208]	_	_
27-25	4379-4386	unifies	event[208]	new[208]	_	_
27-26	4387-4390	the	event[208]|abstract[213]	new[208]|new[213]	coref	29-1[235_213]
27-27	4391-4398	effects	event[208]|abstract[213]	new[208]|new[213]	_	_
27-28	4399-4401	of	event[208]|abstract[213]	new[208]|new[213]	_	_
27-29	4402-4412	prebiotics	event[208]|abstract[213]|substance	new[208]|new[213]|giv	coref	28-16
27-30	4413-4419	across	event[208]	new[208]	_	_
27-31	4420-4423	the	event[208]|animal[215]	new[208]|new[215]	_	_
27-32	4424-4429	flock	event[208]|animal[215]	new[208]|new[215]	_	_
27-33	4430-4433	and	event[208]	new[208]	_	_
27-34	4434-4441	ensures	event[208]	new[208]	_	_
27-35	4442-4448	proper	event[208]|event[216]	new[208]|new[216]	_	_
27-36	4449-4460	development	event[208]|event[216]	new[208]|new[216]	_	_
27-37	4461-4463	of	event[208]|event[216]	new[208]|new[216]	_	_
27-38	4464-4467	gut	event[208]|event[216]|abstract|substance[218]	new[208]|new[216]|giv|giv[218]	coref	32-31
27-39	4468-4478	microflora	event[208]|event[216]|substance[218]	new[208]|new[216]|giv[218]	_	_
27-40	4479-4481	in	event[208]|event[216]	new[208]|new[216]	_	_
27-41	4482-4485	all	event[208]|event[216]|animal[219]	new[208]|new[216]|giv[219]	_	_
27-42	4486-4492	chicks	event[208]|event[216]|animal[219]	new[208]|new[216]|giv[219]	_	_
27-43	4493-4494	.	_	_	_	_

#Text=Studies conducted in the temperate climatic condition have already revealed that in ovo injection of prebiotics and probiotics into the air cell during embryogenesis improves egg hatchability and modulate the optimal composition of the chicken ’s microbiota , fully developed at hatching .
28-1	4495-4502	Studies	abstract[220]	new[220]	_	_
28-2	4503-4512	conducted	abstract[220]	new[220]	_	_
28-3	4513-4515	in	abstract[220]	new[220]	_	_
28-4	4516-4519	the	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-5	4520-4529	temperate	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-6	4530-4538	climatic	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-7	4539-4548	condition	abstract[220]|abstract[221]	new[220]|new[221]	_	_
28-8	4549-4553	have	_	_	_	_
28-9	4554-4561	already	_	_	_	_
28-10	4562-4570	revealed	_	_	_	_
28-11	4571-4575	that	_	_	_	_
28-12	4576-4578	in	_	_	_	_
28-13	4579-4582	ovo	event[222]	giv[222]	_	_
28-14	4583-4592	injection	event[222]	giv[222]	_	_
28-15	4593-4595	of	event[222]	giv[222]	_	_
28-16	4596-4606	prebiotics	event[222]|substance|substance[224]	giv[222]|giv|giv[224]	coref|coref	28-16[224_0]|30-6[246_224]
28-17	4607-4610	and	event[222]|substance[224]	giv[222]|giv[224]	_	_
28-18	4611-4621	probiotics	event[222]|substance[224]|abstract	giv[222]|giv[224]|new	_	_
28-19	4622-4626	into	event[222]	giv[222]	_	_
28-20	4627-4630	the	event[222]|object[227]	giv[222]|new[227]	_	_
28-21	4631-4634	air	event[222]|abstract|object[227]	giv[222]|giv|new[227]	_	_
28-22	4635-4639	cell	event[222]|object[227]	giv[222]|new[227]	_	_
28-23	4640-4646	during	event[222]|object[227]	giv[222]|new[227]	_	_
28-24	4647-4660	embryogenesis	event[222]|object[227]|event	giv[222]|new[227]|new	_	_
28-25	4661-4669	improves	_	_	_	_
28-26	4670-4673	egg	object|event[230]	giv|new[230]	_	_
28-27	4674-4686	hatchability	event[230]	new[230]	_	_
28-28	4687-4690	and	_	_	_	_
28-29	4691-4699	modulate	_	_	_	_
28-30	4700-4703	the	abstract[231]	new[231]	_	_
28-31	4704-4711	optimal	abstract[231]	new[231]	_	_
28-32	4712-4723	composition	abstract[231]	new[231]	_	_
28-33	4724-4726	of	abstract[231]	new[231]	_	_
28-34	4727-4730	the	abstract[231]|substance[233]	new[231]|giv[233]	_	_
28-35	4731-4738	chicken	abstract[231]|animal[232]|substance[233]	new[231]|new[232]|giv[233]	coref	29-8[236_232]
28-36	4739-4741	’s	abstract[231]|animal[232]|substance[233]	new[231]|new[232]|giv[233]	_	_
28-37	4742-4752	microbiota	abstract[231]|substance[233]	new[231]|giv[233]	_	_
28-38	4753-4754	,	abstract[231]	new[231]	_	_
28-39	4755-4760	fully	abstract[231]	new[231]	_	_
28-40	4761-4770	developed	abstract[231]	new[231]	_	_
28-41	4771-4773	at	abstract[231]	new[231]	_	_
28-42	4774-4782	hatching	abstract[231]|event	new[231]|new	_	_
28-43	4783-4784	.	_	_	_	_

#Text=These effects are reportedly stable throughout the chicken ’s lifespan , influencing metabolic and immune responses of the host , resulting in improvement in performance and meat quality .
29-1	4785-4790	These	abstract[235]	giv[235]	_	_
29-2	4791-4798	effects	abstract[235]	giv[235]	_	_
29-3	4799-4802	are	_	_	_	_
29-4	4803-4813	reportedly	_	_	_	_
29-5	4814-4820	stable	_	_	_	_
29-6	4821-4831	throughout	_	_	_	_
29-7	4832-4835	the	abstract[237]	new[237]	_	_
29-8	4836-4843	chicken	animal[236]|abstract[237]	giv[236]|new[237]	_	_
29-9	4844-4846	’s	animal[236]|abstract[237]	giv[236]|new[237]	_	_
29-10	4847-4855	lifespan	abstract[237]	new[237]	_	_
29-11	4856-4857	,	_	_	_	_
29-12	4858-4869	influencing	_	_	_	_
29-13	4870-4879	metabolic	abstract[238]	new[238]	_	_
29-14	4880-4883	and	abstract[238]	new[238]	_	_
29-15	4884-4890	immune	abstract[238]	new[238]	_	_
29-16	4891-4900	responses	abstract[238]	new[238]	_	_
29-17	4901-4903	of	abstract[238]	new[238]	_	_
29-18	4904-4907	the	abstract[238]|animal[239]	new[238]|giv[239]	_	_
29-19	4908-4912	host	abstract[238]|animal[239]	new[238]|giv[239]	_	_
29-20	4913-4914	,	_	_	_	_
29-21	4915-4924	resulting	_	_	_	_
29-22	4925-4927	in	_	_	_	_
29-23	4928-4939	improvement	abstract[240]	new[240]	_	_
29-24	4940-4942	in	abstract[240]	new[240]	_	_
29-25	4943-4954	performance	abstract[240]|abstract	new[240]|giv	coref	32-21[269_0]
29-26	4955-4958	and	abstract[240]	new[240]	_	_
29-27	4959-4963	meat	abstract[240]|substance|abstract[243]	new[240]|new|giv[243]	coref|coref	30-24|32-27[273_243]
29-28	4964-4971	quality	abstract[240]|abstract[243]	new[240]|giv[243]	_	_
29-29	4972-4973	.	_	_	_	_

#Text=However , the efficacy of in ovo delivered prebiotics has been evaluated mainly under fully controlled disease-free experimental conditions in the temperate using meat type chickens .
30-1	4974-4981	However	_	_	_	_
30-2	4982-4983	,	_	_	_	_
30-3	4984-4987	the	abstract[244]	giv[244]	ana	31-5[0_244]
30-4	4988-4996	efficacy	abstract[244]	giv[244]	_	_
30-5	4997-4999	of	abstract[244]	giv[244]	_	_
30-6	5000-5002	in	abstract[244]|substance[246]	giv[244]|giv[246]	coref	31-9[0_246]
30-7	5003-5006	ovo	abstract[244]|abstract|substance[246]	giv[244]|new|giv[246]	coref	32-6[263_0]
30-8	5007-5016	delivered	abstract[244]|substance[246]	giv[244]|giv[246]	_	_
30-9	5017-5027	prebiotics	abstract[244]|substance[246]	giv[244]|giv[246]	_	_
30-10	5028-5031	has	_	_	_	_
30-11	5032-5036	been	_	_	_	_
30-12	5037-5046	evaluated	_	_	_	_
30-13	5047-5053	mainly	_	_	_	_
30-14	5054-5059	under	_	_	_	_
30-15	5060-5065	fully	abstract[247]	giv[247]	coref	31-13[256_247]
30-16	5066-5076	controlled	abstract[247]	giv[247]	_	_
30-17	5077-5089	disease-free	abstract[247]	giv[247]	_	_
30-18	5090-5102	experimental	abstract[247]	giv[247]	_	_
30-19	5103-5113	conditions	abstract[247]	giv[247]	_	_
30-20	5114-5116	in	abstract[247]	giv[247]	_	_
30-21	5117-5120	the	abstract[247]|place[248]	giv[247]|new[248]	_	_
30-22	5121-5130	temperate	abstract[247]|place[248]	giv[247]|new[248]	_	_
30-23	5131-5136	using	abstract[247]|place[248]	giv[247]|new[248]	_	_
30-24	5137-5141	meat	abstract[247]|place[248]|substance|animal[250]|animal[251]	giv[247]|new[248]|giv|new[250]|giv[251]	coref|coref	32-27|32-44[280_251]
30-25	5142-5146	type	abstract[247]|place[248]|animal[250]|animal[251]	giv[247]|new[248]|new[250]|giv[251]	_	_
30-26	5147-5155	chickens	abstract[247]|place[248]|animal[251]	giv[247]|new[248]|giv[251]	_	_
30-27	5156-5157	.	_	_	_	_

#Text=In this study , it was hypothesized that prebiotics perform differently under field conditions in the tropics where management and environmental factors predispose birds to enteric diseases .
31-1	5158-5160	In	_	_	_	_
31-2	5161-5165	this	abstract[252]	new[252]	_	_
31-3	5166-5171	study	abstract[252]	new[252]	_	_
31-4	5172-5173	,	_	_	_	_
31-5	5174-5176	it	abstract	giv	_	_
31-6	5177-5180	was	_	_	_	_
31-7	5181-5193	hypothesized	_	_	_	_
31-8	5194-5198	that	_	_	_	_
31-9	5199-5209	prebiotics	substance	giv	_	_
31-10	5210-5217	perform	_	_	_	_
31-11	5218-5229	differently	_	_	_	_
31-12	5230-5235	under	_	_	_	_
31-13	5236-5241	field	place|abstract[256]	new|giv[256]	coref	32-48[281_256]
31-14	5242-5252	conditions	abstract[256]	giv[256]	_	_
31-15	5253-5255	in	abstract[256]	giv[256]	_	_
31-16	5256-5259	the	abstract[256]|abstract[257]	giv[256]|new[257]	_	_
31-17	5260-5267	tropics	abstract[256]|abstract[257]	giv[256]|new[257]	_	_
31-18	5268-5273	where	abstract[256]|abstract[257]	giv[256]|new[257]	_	_
31-19	5274-5284	management	abstract[256]|abstract[257]|person|abstract[259]	giv[256]|new[257]|giv|new[259]	_	_
31-20	5285-5288	and	abstract[256]|abstract[257]|abstract[259]	giv[256]|new[257]|new[259]	_	_
31-21	5289-5302	environmental	abstract[256]|abstract[257]|abstract[259]	giv[256]|new[257]|new[259]	_	_
31-22	5303-5310	factors	abstract[256]|abstract[257]|abstract[259]	giv[256]|new[257]|new[259]	_	_
31-23	5311-5321	predispose	abstract[256]|abstract[257]	giv[256]|new[257]	_	_
31-24	5322-5327	birds	abstract[256]|abstract[257]|animal	giv[256]|new[257]|new	_	_
31-25	5328-5330	to	abstract[256]|abstract[257]	giv[256]|new[257]	_	_
31-26	5331-5338	enteric	abstract[256]|abstract[257]|abstract[261]	giv[256]|new[257]|new[261]	_	_
31-27	5339-5347	diseases	abstract[256]|abstract[257]|abstract[261]	giv[256]|new[257]|new[261]	_	_
31-28	5348-5349	.	_	_	_	_

#Text=Thus , the efficacy of in ovo delivered prebiotics , antibiotic-chick formula , and a combination of the two on growth performance , carcass traits , meat quality , and gut health in the face of a natural coccidiosis infection was assessed in Kuroiler chickens reared under field conditions in Uganda .
32-1	5350-5354	Thus	_	_	_	_
32-2	5355-5356	,	_	_	_	_
32-3	5357-5360	the	abstract[262]	new[262]	_	_
32-4	5361-5369	efficacy	abstract[262]	new[262]	_	_
32-5	5370-5372	of	abstract[262]	new[262]	_	_
32-6	5373-5375	in	abstract[262]|abstract[263]|substance[264]	new[262]|giv[263]|new[264]	_	_
32-7	5376-5379	ovo	abstract[262]|abstract[263]|substance[264]	new[262]|giv[263]|new[264]	_	_
32-8	5380-5389	delivered	abstract[262]|substance[264]	new[262]|new[264]	_	_
32-9	5390-5400	prebiotics	abstract[262]|substance[264]	new[262]|new[264]	_	_
32-10	5401-5402	,	abstract[262]	new[262]	_	_
32-11	5403-5419	antibiotic-chick	abstract[262]|substance[265]	new[262]|new[265]	_	_
32-12	5420-5427	formula	abstract[262]|substance[265]	new[262]|new[265]	_	_
32-13	5428-5429	,	abstract[262]	new[262]	_	_
32-14	5430-5433	and	abstract[262]	new[262]	_	_
32-15	5434-5435	a	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-16	5436-5447	combination	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-17	5448-5450	of	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-18	5451-5454	the	abstract[262]|abstract[266]|abstract[267]	new[262]|new[266]|new[267]	_	_
32-19	5455-5458	two	abstract[262]|abstract[266]|abstract[267]	new[262]|new[266]|new[267]	_	_
32-20	5459-5461	on	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-21	5462-5468	growth	abstract[262]|abstract[266]|abstract|abstract[269]	new[262]|new[266]|giv|giv[269]	_	_
32-22	5469-5480	performance	abstract[262]|abstract[266]|abstract[269]	new[262]|new[266]|giv[269]	_	_
32-23	5481-5482	,	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-24	5483-5490	carcass	abstract[262]|abstract[266]|object|abstract[271]	new[262]|new[266]|new|giv[271]	_	_
32-25	5491-5497	traits	abstract[262]|abstract[266]|abstract[271]	new[262]|new[266]|giv[271]	_	_
32-26	5498-5499	,	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-27	5500-5504	meat	abstract[262]|abstract[266]|substance|abstract[273]	new[262]|new[266]|giv|giv[273]	_	_
32-28	5505-5512	quality	abstract[262]|abstract[266]|abstract[273]	new[262]|new[266]|giv[273]	_	_
32-29	5513-5514	,	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-30	5515-5518	and	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-31	5519-5522	gut	abstract[262]|abstract[266]|abstract|abstract[275]	new[262]|new[266]|giv|giv[275]	_	_
32-32	5523-5529	health	abstract[262]|abstract[266]|abstract[275]	new[262]|new[266]|giv[275]	_	_
32-33	5530-5532	in	abstract[262]|abstract[266]	new[262]|new[266]	_	_
32-34	5533-5536	the	abstract[262]|abstract[266]|object[276]	new[262]|new[266]|new[276]	_	_
32-35	5537-5541	face	abstract[262]|abstract[266]|object[276]	new[262]|new[266]|new[276]	_	_
32-36	5542-5544	of	abstract[262]|abstract[266]|object[276]	new[262]|new[266]|new[276]	_	_
32-37	5545-5546	a	abstract[262]|abstract[266]|object[276]|event[278]	new[262]|new[266]|new[276]|giv[278]	_	_
32-38	5547-5554	natural	abstract[262]|abstract[266]|object[276]|event[278]	new[262]|new[266]|new[276]|giv[278]	_	_
32-39	5555-5566	coccidiosis	abstract[262]|abstract[266]|object[276]|abstract|event[278]	new[262]|new[266]|new[276]|giv|giv[278]	_	_
32-40	5567-5576	infection	abstract[262]|abstract[266]|object[276]|event[278]	new[262]|new[266]|new[276]|giv[278]	_	_
32-41	5577-5580	was	_	_	_	_
32-42	5581-5589	assessed	_	_	_	_
32-43	5590-5592	in	_	_	_	_
32-44	5593-5601	Kuroiler	person|animal[280]	new|giv[280]	_	_
32-45	5602-5610	chickens	animal[280]	giv[280]	_	_
32-46	5611-5617	reared	animal[280]	giv[280]	_	_
32-47	5618-5623	under	animal[280]	giv[280]	_	_
32-48	5624-5629	field	animal[280]|abstract[281]	giv[280]|giv[281]	_	_
32-49	5630-5640	conditions	animal[280]|abstract[281]	giv[280]|giv[281]	_	_
32-50	5641-5643	in	animal[280]	giv[280]	_	_
32-51	5644-5650	Uganda	animal[280]|place	giv[280]|giv	_	_
32-52	5651-5652	.	_	_	_	_
